Moving medical care to the patient, rather than vice versa, can produce better and faster healthcare at lower cost. The complete blood count (CBC) is the most commonly ordered blood test. It’s run hundreds of millions of times a year in the US alone. But no truly portable device can yet perform a complete blood count (CBC) with a five part differential at the point of care. And no currently available device, portable or not, can perform a  CBC along with simultaneous immunoassays, immunocytometry, serology and other important diagnostic blood tests rapidly and easily on a single pinprick droplet of blood at very low cost.

These tests today typically require skilled phlebotomists to draw blood that is sent to a central laboratory for analysis on expensive devices operated by trained technologists. This process can take hours or days. It’s inconvenient for patients, forcing them to make multiple trips. It adds significant delay and expense to the nation’s health care bill. The need for phlebotomists and expensive instruments makes even this most basic blood test unavailable in many clinics and in remote locations, and unnecessarily increases expense everywhere.

Alentic’s highly portable, low-cost, lensless technology, protected by more than 30 US patents, can eliminate many of these problems. Our pocket-sized, easy to use devices need no skilled technologists or phlebotomists. They provide results in minutes, and can help deliver key diagnostic tests to anyone, anywhere, whenever and wherever needed, all at a cost well below current industry standards.

And CBCs are just the beginning of the lensless revolution. Future versions of our device, already in development, will perform rapid point of care testing for sepsis, sexually transmitted diseases, and a wide range of other conditions:  again, all at the point of care, and all from a pinprick of blood with no need for phlebotomists or central labs. While many of these tests can today cost hundreds of dollars, our lensless technology operates with small amounts of dry reagents that need no refrigeration and that have dramatic cost advantages over existing technologies.

Alentic’s technology makes health care more accessible, convenient, and cheaper for patients and doctors alike.